| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-06-15 | Mr. John Adam ZangerleSenior VP, General Counsel & Secretary | -1.42k | 296.97k | 売り | 209.28 | 35.26k | -3.87% |
| 2026-06-04 | Mr. John Adam ZangerleSenior VP, General Counsel & Secretary | -401.00 | 85.11k | Sale to Issuer | 212.24 | 36.68k | -1.08% |
| 2026-06-04 | Mr. Renato G. TamaroVP & Corporate Treasurer | -65.00 | 13.80k | Sale to Issuer | 212.24 | 6.19k | -1.04% |
| 2026-06-04 | Ms. Julia K. MadsenSenior VP & GM of Life Sciences | -195.00 | 41.39k | Sale to Issuer | 212.24 | 12.26k | -1.57% |
| 2026-06-04 | Mr. Kenneth E. KohlerSenior VP & GM of AST | -150.00 | 31.84k | Sale to Issuer | 212.24 | 11.33k | -1.31% |
| 2026-06-04 | Ms. Mary Clare FraserSVP & Chief HR Officer | -600.00 | 127.34k | Sale to Issuer | 212.24 | 13.72k | -4.19% |
| 2026-06-04 | Mr. Daniel A. CarestioPresident, CEO & Director | -1.89k | 400.92k | Sale to Issuer | 212.24 | 63.65k | -2.88% |
| 2026-06-04 | Mr. Daniel A. CarestioPresident, CEO & Director | -4.43k | 946.80k | 売り | 212.00 - 214.64 | 63.65k | -6.50% |
| 2026-06-04 | Ms. Karen L. BurtonSenior VP, CFO & CAO | -90.00 | 19.10k | Sale to Issuer | 212.24 | 13.18k | -0.68% |
| 2026-06-03 | Ms. Julia K. MadsenSenior VP & GM of Life Sciences | -239.00 | 50.24k | Sale to Issuer | 210.19 | 12.45k | -1.88% |
| 2026-06-03 | Mr. Renato G. TamaroVP & Corporate Treasurer | -64.00 | 13.45k | Sale to Issuer | 210.19 | 6.26k | -1.01% |
| 2026-06-03 | Mr. John Adam ZangerleSenior VP, General Counsel & Secretary | -365.00 | 76.72k | Sale to Issuer | 210.19 | 37.08k | -0.97% |
| 2026-06-03 | Mr. Kenneth E. KohlerSenior VP & GM of AST | -184.00 | 38.67k | Sale to Issuer | 210.19 | 11.48k | -1.58% |
| 2026-06-03 | Ms. Mary Clare FraserSVP & Chief HR Officer | -311.00 | 65.37k | Sale to Issuer | 210.19 | 14.32k | -2.13% |
| 2026-06-03 | Ms. Karen L. BurtonSenior VP, CFO & CAO | -190.00 | 39.94k | Sale to Issuer | 210.19 | 13.27k | -1.41% |
| 2026-06-03 | Mr. Daniel A. CarestioPresident, CEO & Director | -2.62k | 550.49k | Sale to Issuer | 210.19 | 69.96k | -3.61% |
| 2026-06-02 | Mr. Renato G. TamaroVP & Corporate Treasurer | -41.00 | 8.60k | Sale to Issuer | 209.76 | 6.32k | -0.64% |
| 2026-06-02 | Mr. John Adam ZangerleSenior VP, General Counsel & Secretary | -247.00 | 51.81k | Sale to Issuer | 209.76 | 37.44k | -0.66% |
| 2026-06-02 | Ms. Julia K. MadsenSenior VP & GM of Life Sciences | -127.00 | 26.64k | Sale to Issuer | 209.76 | 12.69k | -0.99% |
| 2026-06-02 | Mr. Cary L. MajorsSenior VP & President of Healthcare | -67.00 | 14.05k | Sale to Issuer | 209.76 | 17.41k | -0.38% |
| 2026-06-02 | Ms. Lindsey McGowanVP, Chief Compliance & Quality Officer | -329.00 | 69.01k | Sale to Issuer | 209.76 | 5.91k | -5.27% |
| 2026-06-02 | Ms. Mary Clare FraserSVP & Chief HR Officer | -591.00 | 123.97k | Sale to Issuer | 209.76 | 14.63k | -3.88% |
| 2026-06-02 | Mr. Kenneth E. KohlerSenior VP & GM of AST | -66.00 | 13.84k | Sale to Issuer | 209.76 | 11.67k | -0.56% |
| 2026-06-02 | Mr. Daniel A. CarestioPresident, CEO & Director | -995.00 | 208.71k | Sale to Issuer | 209.76 | 72.58k | -1.35% |
| 2026-06-02 | Ms. Karen L. BurtonSenior VP, CFO & CAO | -66.00 | 13.84k | Other Disposition | 209.76 | 13.46k | -0.49% |
| 2026-06-02 | Mr. Richard Carroll BreedenIndependent Director | 2.30k | 164.22k | Derivative Exercise and Retained Stock | 71.40 | 38.96k | 6.27% |
| 2026-06-02 | Mr. Richard Carroll BreedenIndependent Director | -1.48k | 204.54k | Derivative Exercise and Sale | 71.40 - 209.51 | 38.96k | - |
| 2026-06-01 | Ms. Lindsey McGowanVP, Chief Compliance & Quality Officer | -198.00 | 0.00 | Sale to Issuer | - | 5.09k | -3.75% |
| 2026-06-01 | Mr. Renato G. TamaroVP & Corporate Treasurer | -81.00 | 0.00 | Sale to Issuer | - | 5.61k | -1.42% |
| 2026-06-01 | Mr. John Adam ZangerleSenior VP, General Counsel & Secretary | -337.00 | 0.00 | Sale to Issuer | - | 33.33k | -1.00% |
| 2026-06-01 | Mr. Cary L. MajorsSenior VP & President of Healthcare | -768.00 | 0.00 | Sale to Issuer | - | 12.73k | -5.69% |
| 2026-06-01 | Ms. Julia K. MadsenSenior VP & GM of Life Sciences | -208.00 | 0.00 | Sale to Issuer | - | 10.50k | -1.94% |
| 2026-06-01 | Mr. Daniel A. CarestioPresident, CEO & Director | -1.25k | 0.00 | Sale to Issuer | - | 49.84k | -2.45% |
| 2026-06-01 | Ms. Mary Clare FraserSVP & Chief HR Officer | -673.00 | 0.00 | Sale to Issuer | - | 12.21k | -5.22% |
| 2026-06-01 | Mr. Kenneth E. KohlerSenior VP & GM of AST | -109.00 | 0.00 | Sale to Issuer | - | 9.53k | -1.13% |
| 2026-06-01 | Ms. Karen L. BurtonSenior VP, CFO & CAO | -99.00 | 0.00 | Sale to Issuer | - | 8.21k | -1.19% |
| 2026-03-05 | Ms. Cynthia L. FeldmannIndependent Director | -3.10k | 262.99k | Derivative Exercise and Sale | 152.32 - 237.21 | 9.37k | - |
| 2025-11-21 | Ms. Julia K. MadsenSenior VP & GM of Life Sciences | -5.01k | 669.96k | Derivative Exercise and Sale | 114.22 - 262.00 | 10.71k | - |
| 2025-11-18 | Mr. Renato G. TamaroVP & Corporate Treasurer | -3.54k | 266.07k | Derivative Exercise and Sale | 182.22 - 258.03 | 5.70k | - |
| 2025-11-18 | Mr. Renato G. TamaroVP & Corporate Treasurer | -1.50k | 386.64k | 売り | 257.76 | 5.70k | -20.85% |
| 2025-11-11 | Mr. John Adam ZangerleSenior VP, General Counsel & Secretary | -15.00k | 2.93M | Derivative Exercise and Sale | 69.72 - 265.14 | 33.67k | - |
| 2025-10-06 | Mr. Daniel A. CarestioPresident, CEO & Director | -159.00 | 38.45k | 売り | 241.82 | 51.10k | -0.31% |
| 2025-10-01 | Mr. Renato G. TamaroVP & Corporate Treasurer | -26.00 | 0.00 | Sale to Issuer | - | 7.20k | -0.36% |
| 2025-10-01 | Mr. John Adam ZangerleSenior VP, General Counsel & Secretary | -91.00 | 0.00 | Sale to Issuer | - | 33.67k | -0.27% |
| 2025-10-01 | Mr. Cary L. MajorsSenior VP & President of Healthcare | -303.00 | 0.00 | Sale to Issuer | - | 13.49k | -2.20% |
| 2025-10-01 | Ms. Mary Clare FraserSVP & Chief HR Officer | -207.00 | 0.00 | Sale to Issuer | - | 12.88k | -1.58% |
| 2025-10-01 | Ms. Julia K. MadsenSenior VP & GM of Life Sciences | -52.00 | 0.00 | Sale to Issuer | - | 10.71k | -0.48% |
| 2025-10-01 | Ms. Karen L. BurtonSenior VP, CFO & CAO | -39.00 | 0.00 | Sale to Issuer | - | 8.30k | -0.47% |
| 2025-10-01 | Mr. Daniel A. CarestioPresident, CEO & Director | -130.00 | 0.00 | Sale to Issuer | - | 51.26k | -0.25% |
| 2025-08-20 | Mr. Renato G. TamaroVP & Corporate Treasurer | -3.20k | 327.42k | Derivative Exercise and Sale | 147.05 - 249.24 | 7.22k | - |
| 2025-08-13 | Mr. Richard Carroll BreedenIndependent Director | 4.11k | 263.25k | Derivative Exercise and Retained Stock | 64.05 | 36.66k | 12.63% |
| 2025-08-11 | Dr. Mohsen M. SohiIndependent Chairman of the Board | -4.11k | 731.21k | Derivative Exercise and Sale | 64.05 - 241.96 | 22.36k | - |
| 2025-08-11 | Ms. Cynthia L. FeldmannIndependent Director | -3.50k | 844.25k | Derivative Exercise and Sale | 241.56 | 9.37k | - |
| 2025-08-11 | Ms. Karen L. BurtonSenior VP, CFO & CAO | -7.90k | 1.01M | Derivative Exercise and Sale | 114.22 - 241.73 | 5.99k | - |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。